Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
chemotherapy plus TCM 1&ICIs plusTCM2
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
chlorhexidine acetate gargle
Peking University Third Hospital
Esophageal Cancer
1 trial -
cipher prescription 1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Percutaneous Coronary Artery Intervention
1 trial -
circulate free methylated EBV DNA
The First People's Hospital of Lianyungang
Extranodal Natural Killer/T-cell Lymphoma
1 trial -
clomiphene citrate
Ultragenyx UK Limited
Hyperinsulinism
1 trial -
conventional radiotherapy 74 Gy delivered in 37 fractions
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
dexmedetomidine
The First People's Hospital of Lianyungang
Children
1 trial -
dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Anesthesia
1 trial -
diet management strategy for encephalopathy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatic Encephalopathy
1 trial -
dopamine
The First People's Hospital of Lianyungang
Renal Artery Stenosis Atherosclerotic
1 trial -
drug
The First People's Hospital of Lianyungang
Hypertension
1 trial -
esketamine group
The First People's Hospital of Lianyungang
Postherpetic Neuralgia
1 trial -
etomidate anesthesia
Xiyuan Hospital of China Academy of Chinese Medical Sciences
General Anesthesia
1 trial -
evolocumab
Beijing Luhe Hospital
STEMI
1 trial -
extended release niacin
United Therapeutics Europe Ltd
HIV Infections
1 trial -
extensively hydrolyzed rice protein formula
United Therapeutics Europe Ltd
Milk Hypersensitivity
1 trial -
fecal microbiota transplantation
The First People's Hospital of Lianyungang
Fecal Microbiota Transplantation
1 trial -
fentanyl
Hospital Authority, Hong Kong
Anesthesia, Spinal
1 trial -
fludeoxyglucose F 18
United Therapeutics Europe Ltd
Lung Cancer
1 trial -
fludeoxyglucose F 18
United Therapeutics Europe Ltd
Testicular Germ Cell Tumor
1 trial -
foundational treatment
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
goserelin acetate
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
high caloric oral nutritional supplements
The First People's Hospital of Lianyungang
Malnutrition, Child
1 trial -
high-energy digestible food E2
The First People's Hospital of Lianyungang
Caesarean Section
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources